Featured
The Structural Retrofit: How Genomic Sovereignty and Metabolic Pharmaceuticals Are Rewriting Public Health Economics
This week's convergence of the WHO Pandemic Treaty, CDC GLP-1 mortality data, and FDA OTC CGM approval signals a definitive pivot in public health fro...
Read Full Story →